Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 178,660 | 182,970 | 165,719 | 164,214 | 77,068 |
| TOTAL | $189,049 | $195,082 | $177,269 | $173,165 | $87,989 |
| Non-Current Assets | |||||
| PPE Net | 50,558 | 18,233 | 10,492 | 9,070 | 8,571 |
| Intangibles | 0 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 1,293 | 1,339 | 1,284 | 1,166 | 1,503 |
| TOTAL | $51,851 | $19,692 | $11,896 | $10,356 | $10,194 |
| Total Assets | $240,900 | $214,774 | $189,165 | $183,521 | $98,183 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,282 | 7,964 | 3,406 | 2,859 | 4,598 |
| Accrued Expenses | 7,945 | 3,479 | 4,211 | 2,783 | 4,626 |
| TOTAL | $21,716 | $12,026 | $8,081 | $6,028 | $9,819 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 467 | 530 | 591 | 577 | 716 |
| TOTAL | $467 | $530 | $591 | $577 | $716 |
| Total Liabilities | $22,183 | $12,556 | $8,672 | $6,605 | $10,535 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 533,929 | 439,590 | 357,522 | 326,509 | 323,918 |
| Common Shares | 16 | 404 | 346 | 324 | 206 |
| Retained earnings | -359,820 | -330,267 | -311,739 | -288,186 | -267,533 |
| Other shareholders' equity | -92 | -81 | -71 | -63 | -62 |
| TOTAL | $218,717 | $202,218 | $180,493 | $176,916 | $87,648 |
| Total Liabilities And Equity | $240,900 | $214,774 | $189,165 | $183,521 | $98,183 |